Skip to main content

Posts

Uterine Cancer Drugs Market is Expected to Gain Popularity Across the Globe by 2028

  Uterine cancer is one of the most common gynecologic malignancy among female cancer patients. This uterine cancer is of two types: endometrial cancer and uterine sarcoma. Endometrial cancer is caused due to uncontrolled growth of inner linings of uterus. Endometrial cancer is often curable, however, uterine sarcoma is rare cancer, which develops in the muscle and supporting tissues of the uterus (womb). According to National Cancer Institute, Megestrol Acetate is only drug approved by U.S. Food and Drug Administration (FDA) for the treatment of endometrial cancer till March 2016. Diagnosis of both types of uterine cancer is done through endometrial biopsy, colposcopy or Pap smear screening test. Uterine Cancer Drugs Market Drivers Increasing funding for cancer research, rising insurance coverage, and increasing number of new targeted cancer drugs are supporting the revenue growth of uterine cancer drugs market size. For instance, National Cancer Institute, in 2015, invested ...

Mitochondrial Disorders Treatment Market Development Analysis Contributing Top Vendor Landscape and Economic Growth 2028

  Mitochondrial disorders are inherited chronic disorders characterized by a wide range of biochemical and genetic mitochondrial defects and mutations. The disorder affects multiple organs, which includes brain, heart, liver, skeletal muscles, kidney, and respiratory systems. The patients with mitochondrial disorders often suffer from muscle weakness, exercise intolerance, and fatigue due to reduction in mitochondrial respiration, which is caused due to mitochondrial DNA mutations leading to reduced ability to produce cellular adenosine triphosphate (ATP). Despite major advances in understanding of the molecular mechanisms, currently there are no effective treatments for the disease. The treatment of mitochondrial disorders is mostly performed with different vitamins, co-factors, off-label drugs approved for other indications, and nutritional supplements. However, the research organizations and pharmaceutical companies are involved in development of novel drugs with technology adva...

The rising cases of zoonotic diseases to boost Animal Nutrition Market growth

  Market Overview: Animal nutrition  refers to the nutritional necessities of food-production, companion, or service animals . It is the kind of making or design of feed for animals that make food such as milk or meat or nonfood substances. Nutrients are materials in feed that are utilized by the animal for growth and manufacture. Competitive Landscape: Key players involved in the global animal nutrition market are Tata Chemicals, Archer-Daniels-Midland Company, Dow Chemical Company,Evonik Industries AG, Adisseo France SAS, Royal DSM N.V., Kemin Industries, Inc.,   Alltech, BASF SE, Cargill Inc., DuPont, Novozymes A/S, and Nutreco N.V.  Market Key Drivers: The rising cases of zoonotic diseases is expected to propel the growth of global animal nutrition market. For instances, as per WHO, around one billion cases of illness and one million cases of fatalities occur due to zoonoses annually. Increasing demand for safe and nutritious food for animals is antic...

Orthopedic Medical Imaging Market continues to grow with GE Healthcare receiving the U.S. FDA clearance for its OEC 3D, a new surgical imaging system capable of 3D and 2D

  Orthopedic medical imaging has many uses in modern medicine. Some of these include mammography, ultrasound, magnetic resonance imaging (MRI), and tomography. These different types of technology are used in order to help doctors see and treat problems more clearly. Orthopedic medical imaging has become incredibly useful for the diagnosis of various orthopedic diseases. These diseases include arthritis, osteoporosis, Carpal Tunnel Syndrome, ligament injuries, etc. As per the Centers for Disease Control and Prevention (CDC), by 2040, around 78 million U.S. adults aged 18 years and above are estimated to have doctor-diagnosed arthritis. Similarly, as per Beaumont Health, around 100,000 to 200,000 anterior cruciate ligament (ACL) cases occur each year in the U.S. Such injuries and bone-related diseases require accurate diagnosis, for which medical imagining becomes the primary solution. Thus, such factors can augment growth of the orthopedic medical imagining market. Developed count...

The Global Digital Pathology Market Continues To Grow Owing To the Recent Developments Done By Central Market Players in the World

  Market Overview: Digital pathology also offers more options for viewing, marking, and sharing images. It makes it easier for pathologists to search for cases with similar features, share slides with colleagues, and build predictive models. Using cloud storage means pathologists from around the world can access images and collaborate with one another. Using digital slides can also improve patient care. The benefits of digital pathology go beyond the ability to distribute digital slides. Digital images can be used for specialized analytics, some of which incorporate artificial intelligence. There are some downsides to digital pathology, however. It is important to weigh the benefits of digital pathology with its drawbacks. It may cause some delays in the workflow, but the benefits outweigh the disadvantages. Competitive Landscape: Major players operating in the global digital pathology market include Paige, Motic, Mikroscan Technologies, Kanteron Systems, Proscia Inc., PathAI...

Bone Regeneration Material Market: Up-to-Date Analysis of Latest Trends in Market

  Increasing number of orthopedic surgeries is an important factor driving growth of the global bone regeneration materials market. According to the National Center for Biotechnology Information, in 2015, around 7,076 hospital admissions for  total knee arthroplasties  (TKAs) and 13,017 hospital admission for total hip arthroplasties (THAs) were reported in Brazil. Moreover, in 2015, the state of Sao Paulo registered 49% geriatrics in the Southeast region of Brazil, among which accounted 47.4% for TKAs and 53.8% for THAs. Similarly, the increasing incidence of osteoarthritis among the global population is expected to drive growth of global bone regeneration materials market during the forecast period. According to data published by the Arthritis Foundation in November 2017, arthritis was the leading cause of disability among adults in the U.S. Over 53 million adults worldwide suffered from arthritis, which included over 100 types of joint diseases. This is expected to ...

Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market is Expected to Grow Drastically, Assured By Experts From 2023 To 2028

  Surgical hemostat is a surgical tool used in many surgical procedures to control bleeding. Surgical hemostats covered in this report include thrombin-based, combination hemostats, oxidized regenerated cellulose-based, gelatin-based, and collagen-based. Internal tissue sealants are typically used in surgeries to bind or hold internal tissues such as blood vessels, internal organs, bone cartilage, dura matter and others. The global surgical hemostats, internal tissue sealants and adhesion barriers market is estimated to account for US$ 4,231.4 Mn in terms of value in 2020 and is expected to reach US$ 7,346.7 Mn by the end of 2027 Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Drivers Increasing number of surgical procedures is expected to propel growth of the global surgical  hemostats , internal tissue sealants and adhesion barriers market over the forecast period. For instance, according to ‘Surgical operations and procedures sta...